GUIDERI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 6.423
EU - Europa 5.347
AS - Asia 3.110
SA - Sud America 587
AF - Africa 203
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
Totale 15.697
Nazione #
US - Stati Uniti d'America 6.308
RU - Federazione Russa 1.201
CN - Cina 1.076
SG - Singapore 964
GB - Regno Unito 840
IE - Irlanda 767
IT - Italia 569
DE - Germania 519
BR - Brasile 488
SE - Svezia 466
VN - Vietnam 308
FR - Francia 303
UA - Ucraina 299
HK - Hong Kong 249
FI - Finlandia 145
KR - Corea 123
ZA - Sudafrica 113
IN - India 90
BD - Bangladesh 59
CA - Canada 56
ES - Italia 48
IQ - Iraq 34
MX - Messico 33
JP - Giappone 28
TR - Turchia 27
NG - Nigeria 26
NL - Olanda 26
AR - Argentina 25
PL - Polonia 24
AT - Austria 23
CI - Costa d'Avorio 23
EC - Ecuador 23
BE - Belgio 20
CZ - Repubblica Ceca 20
PK - Pakistan 18
AU - Australia 17
IR - Iran 15
CO - Colombia 14
GR - Grecia 14
CL - Cile 12
ID - Indonesia 12
AE - Emirati Arabi Uniti 11
MA - Marocco 11
SA - Arabia Saudita 11
UZ - Uzbekistan 11
KE - Kenya 9
PH - Filippine 9
JM - Giamaica 8
JO - Giordania 8
VE - Venezuela 8
BG - Bulgaria 7
OM - Oman 7
EG - Egitto 6
KG - Kirghizistan 6
LT - Lituania 6
MY - Malesia 6
SI - Slovenia 6
TN - Tunisia 6
EE - Estonia 5
EU - Europa 5
IL - Israele 5
NP - Nepal 5
PY - Paraguay 5
RO - Romania 5
BO - Bolivia 4
KZ - Kazakistan 4
LV - Lettonia 4
PT - Portogallo 4
AZ - Azerbaigian 3
BH - Bahrain 3
CH - Svizzera 3
DZ - Algeria 3
HR - Croazia 3
MD - Moldavia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PE - Perù 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
AL - Albania 2
BB - Barbados 2
BN - Brunei Darussalam 2
CR - Costa Rica 2
CY - Cipro 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
MU - Mauritius 2
PA - Panama 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
BS - Bahamas 1
BW - Botswana 1
Totale 15.678
Città #
Dallas 849
Dublin 745
Southend 665
Singapore 528
Fairfield 511
Ashburn 492
Santa Clara 383
Chandler 375
San Jose 330
Moscow 329
Beijing 291
Hong Kong 245
Woodbridge 236
Jacksonville 221
Seattle 197
Wilmington 197
Houston 188
Hefei 176
Cambridge 172
Ann Arbor 166
Menlo Park 165
Princeton 156
Siena 150
Seoul 121
New York 113
The Dalles 105
Johannesburg 101
Los Angeles 99
Lauterbourg 86
Helsinki 85
Nanjing 83
Ho Chi Minh City 75
Hanoi 71
Dearborn 65
Dong Ket 64
Munich 61
Council Bluffs 59
Vimercate 52
Buffalo 50
Milan 50
San Diego 44
São Paulo 44
Boardman 43
Orem 35
London 34
Shanghai 34
San Mateo 33
Nanchang 32
Málaga 30
Florence 29
Frankfurt am Main 27
Abuja 25
Abidjan 23
Bengaluru 23
Redondo Beach 23
Tokyo 23
Shenyang 22
Chicago 21
Tianjin 21
Brussels 20
Mestre 20
Rome 20
San Francisco 20
Toronto 20
Warsaw 19
Washington 19
Columbus 18
Brooklyn 17
Turku 17
Changsha 16
Montreal 16
Baghdad 15
Chennai 15
Guangzhou 15
Pisa 15
Atlanta 14
Belo Horizonte 14
Brno 14
Jiaxing 14
Prato 14
Rio de Janeiro 14
Da Nang 13
Mexico City 13
Kunming 12
Brasília 11
Nuremberg 11
Paris 11
Amsterdam 10
Arezzo 10
Haiphong 10
Lappeenranta 10
Miami 10
Norwalk 10
Tashkent 10
Zhengzhou 10
Bologna 9
City of London 9
Denver 9
Hangzhou 9
Phoenix 9
Totale 10.235
Nome #
Autonomic activity and baroreflex sensitivity in patients submitted to carotid stenting 303
P wave dispersion in cryptogenic stroke: A risk factor for cardioembolism? 298
Systemic thrombolysis for stroke in pregnancy 282
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 280
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans. 276
Predictors of long-term recovery in complex activities of daily living before discharge from the stroke unit 265
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 264
Cardiac autonomic nervous system and risk of arrhythmias in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). 261
Cardiac dysautonomia and serotonin plasma levels in Rett syndrome 260
Relationship between the modified Rankin Scale and the Barthel Index in the process of functional recovery after stroke 254
Cardiac dysautonomia and arterial distensibility in essential hypertensives 251
Autonomic dysfunction in mental retardation and spastic paraparesis with MECP2 mutation. 250
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 244
QTc interval prolongation during infusion with dipyridamole or adenosine 242
Disturbo di panico e coinvolgimento dell'apparato cardiovascolare: modificazioni della variabilita' della frequenza cardiaca (HRV) dopo terapia farmacologica 239
Aortic stiffness in patients with deep and lobar intracerebral hemorrhage: role of antihypertensive drugs and statins: response to letter 234
Cyclosporin and tacrolimus increase plasma levels of adenosine in kidney transplanted patients 233
Anticoagulation after Stroke in Patients with Atrial Fibrillation: To Bridge or Not with Low-Molecular-Weight Heparin? 233
Increased arterial stiffness is an independent risk factor for hemorrhagic transformation in ischemic stroke undergoing thrombolysis 230
Arrhythmogenic effects of anti-Ro/SSA antibodies on theadult heart: more than expected? 230
Eight and a Half Syndrome with Hemiparesis and Hemihypesthesia: The Nine Syndrome? 229
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 225
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 221
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients. 219
Connective tissue diseases and cardiac rhythm disorders: an overview 217
Thrombolytic treatment of cardiac myxoma-induced ischemic stroke: a review 216
Endovascular treatment of early recurrent ischemic stroke following intravenous thrombolysis 214
Causes and Risk Factors of Cerebral Ischemic Events in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention: The RENo Study 213
Early and delayed increase in plasma homocysteine levels in heart transplanted patients. 212
Disturbo di panico e coinvolgimento dell'apparato cardiovascolare: modificazioni della variabilità del tratto R-R dell'elettrocardiogramma in pazienti affetti 212
Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients With Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study 212
Safety of intravenous thrombolysis in ischemic stroke caused by left atrial myxoma 210
Stroke warning syndrome: 18 new cases 210
Safety of anticoagulation in patients treated with urgent reperfusion for ischemic stroke related to atrial fibrillation 197
Mortality in patients with intracerebral hemorrhage associated with antiplatelet agents, oral anticoagulants or no antithrombotic therapy 195
Previous use of statins and atrial electrical remodeling in patients with cryptogenic stroke 191
Anticoagulation in acute ischemic stroke patients with mechanical heart valves: To bridge or not with heparin. The ESTREM study 189
Cardiac dysautonomia and ridk of arrhthmias in subjects wiht CADASIL 189
Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with Non-Vitamin-K oral anticoagulants (RAF-NOACs) Study 187
Acute ischemic stroke and concomitant massive pulmonary embolism: a challenge 184
Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: Time to initiation of oral anticoagulant therapy and outcomes 182
Prognostic value of trans-thoracic echocardiography in patients with acute stroke and atrial fibrillation: findings from the RAF study 181
Sympathetic overactivity and plasma leptin levels in Rett syndrome 181
P wave dispersion and silent atrial fibrillation in cryptogenic stroke: The pathogenic role of inflammation 176
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 173
Blunted increase in plasma adenosine levels following dipyridamole stress test in dilated cardiomyopathy patients 172
Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study. 166
Calcium dobesilate, hemorheology, fibrinolysis and endothelium. New perspectives for the prevention of diabetic microangiopathy. A clinical-pharmacological study 165
Sudden death and cardiac arrhythmias in Rett syndrome 163
Nerve growth factor plasma levels and ventricular repolarization in Rett syndrome 162
Inhibitory effect of synthetic cannabinoids on cytokine production in rheumatoid fibroblast-like synoviocytes 160
Early recurrence in paroxysmal versus sustained atrial fibrillation in patients with acute ischaemic stroke 160
Homocysteine and P wave dispersion in patients with heart transplantation 158
Effects of acetyl-L-carnitine on cardiac dysautonomia in Rett syndrome: prevention of sudden death? 156
Calcium infusion induces myocardial ischaemia in patients with coronary artery disease by a mechanism possibly adenosine mediated 153
Reperfusion therapies in patients with acute ischaemic stroke and atrial fibrillation: data on safety and effectiveness from a multi-centre cohort study 152
Haemorheological changes after thrombolytic trea tment with streptokinase in acute myocardial infarction 146
Autonomic nervous system alterations in Rett syndrome 143
Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study 143
Electrocardiographic Predictors of Silent Atrial Fibrillation in Cryptogenic Stroke 141
Effects of acute administration of iloprost on the cardiac autonomic nervous system and ventricular repolarisation in patients with systemic sclerosis 140
The Impact of Sex and Arterial Stiffness Interactions on the Outcome after an Acute Ischemic Stroke: A Retrospective Cohort Study 138
Cardiac disease and Rett syndrome 138
Increased arterial stiffness is associated with poor collaterals in acute ischemic stroke from large vessel occlusion 138
Increased Arterial Stiffness is a Predictor of Delayed Ischaemic Stroke After Subarachnoid Haemorrhage 136
Oral anticoagulants in the oldest old with recent stroke and atrial fibrillation 132
The risk of stroke recurrence in patients with atrial fibrillation and reduced ejection fraction 129
Markers of atrial cardiopathy in severe embolic strokes of undetermined source 128
Effects of vinburnine on haemorheological parameters and on oxygen equilibrium curve and 2,3-DPG. An in vitro study 126
Timing of initiation of oral anticoagulants in patients with acute ischemic stroke and atrial fibrillation comparing posterior and anterior circulation strokes 125
Hemodynamic and Hemorheologic Effects of IV Dilevalol in Hypertensive Patients 124
null 122
Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy 122
Soluble haemoglobin-induced rheological impairment: A role for oxygen free radical formation 120
Ischemic stroke after heart transplantation 119
Increase in plasma adenosine during brain ischemia in man: A study during transient ischemic attacks, and stroke 115
Non-stenosing carotid atherosclerosis and arterial stiffness in embolic stroke of undetermined source 112
Inflammation and Atrial Electrical Remodelling in Patients With Embolic Strokes of Undetermined Source 110
Reduced heart rate variability in patients affected with Rett syndrome. A possible explanation for sudden death 109
Outcome after acute ischemic stroke treatment during Covid-19 outbreak in South-East Tuscany 107
The calcium I.V. infusion induces an increase of adenosine plasma levels and a coronary steal phenomenon in humans 104
Risk factors for intracerebral hemorrhage in patients with atrial fibrillation on Non-Vitamin K antagonist oral anticoagulants for stroke prevention 100
Sex-related differences in risk factors, type of treatment received and outcomes in patients with atrial fibrillation and acute stroke: Results from the RAF-study (Early Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation) 97
Safety of Intravenous Thrombolysis and Mechanical Thrombectomy in Bilateral Posterior Cerebral Artery Territory Infarction 95
To the Editor— Anticoagulation in atrial fibrillation after intracranial hemorrhage: Could the hemorrhage location influence the outcome? 92
Prestroke CHA2DS2-VASc Score and Severity of Acute Stroke in Patients with Atrial Fibrillation: Findings from RAF Study 82
Progressive cardiac dysautonomia observed in patients affected by classic Rett syndrome and not in the preserved speech variant 78
Echocardiographic evaluation in rett children with cardiac dysautonomia 70
Efficacy and tolerability of flunarizine administered according to different dosage schedules. Multicenter study on 5000 patients [EFFICACIA E TOLLERABILITA DELLA FLUNARIZINA SECONDO DIVERSI SCHEMI POSOLOGICI. STUDIO POLICENTRICO SU 5000 PAZIENTI] 69
The infusion of calcium gluconate in coronary disease patients induces myocardial ischemia via a possible adenosine-mediated mechanism. [L'infusione di calcio gluconato in pazienti coronaropatici induce ischemia miocardica attraverso un possibile meccanismo adenosino-mediato.] 67
null 61
Intravenous thrombolysis in patients with acute ischaemic stroke and active cancer (the ITACA-stroke study) 8
Totale 15.917
Categoria #
all - tutte 53.782
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.782


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021104 0 0 0 0 0 0 0 0 0 0 0 104
2021/20221.154 66 95 37 97 45 16 35 154 99 83 173 254
2022/20231.457 95 165 209 168 116 280 52 113 117 48 75 19
2023/20241.303 52 14 122 50 71 351 398 28 4 21 43 149
2024/20252.503 55 114 215 189 319 158 117 120 237 87 286 606
2025/20265.457 472 810 618 656 1.065 194 672 191 218 317 155 89
Totale 15.917